Cargando…
Evaluation of tissue-engineered human acellular vessels as a Blalock–Taussig–Thomas shunt in a juvenile primate model
OBJECTIVES: Palliative treatment of cyanotic congenital heart disease (CCHD) uses systemic-to-pulmonary conduits, often a modified Blalock–Taussig–Thomas shunt (mBTTs). Expanded polytetrafluoroethylene (ePTFE) mBTTs have associated risks for thrombosis and infection. The Human Acellular Vessel (HAV)...
Autores principales: | Nash, Kevin M., Boe, Brian A., Carrillo, Sergio A., Harrison, Andrew, Iwaki, Ryuma, Kelly, John, Kirkton, Robert D., Krishnamurthy, Ramkumar, Lawson, Jeffrey H., Matsuzaki, Yuichi, Prichard, Heather L., Shah, Kejal, Shinoka, Toshiharu, Breuer, Christopher K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556952/ https://www.ncbi.nlm.nih.gov/pubmed/37808023 http://dx.doi.org/10.1016/j.xjon.2023.05.018 |
Ejemplares similares
-
The Blalock and Taussig Shunt Revisited
por: Kiran, Usha, et al.
Publicado: (2017) -
Management of failing bidirectional cavopulmonary shunt: Influence of additional systemic-to-pulmonary-artery shunt with classic Glenn physiology
por: Euringer, Caecilia, et al.
Publicado: (2022) -
Surgical repair of Tetralogy of Fallot following primary palliation: Right ventricular outflow track stenting versus modified Blalock-Taussig shunt
por: Bigdelian, Hamid, et al.
Publicado: (2018) -
An alternative technique for downsizing a modified Blalock‐Taussig shunt
por: Bobos, Dimitrios, et al.
Publicado: (2018) -
Near-Infrared Spectroscopy: An Important Tool during the Blalock-Taussig Shunt
por: Lamba, Aditya, et al.
Publicado: (2020)